1 | oral | 36,448 |
2 | intravaginal | 485 |
3 | liuwei | 30 |
4 | macrocrystalline | 18 |
5 | 5-hydroxymethyl | 15 |
6 | nonoral | 15 |
7 | d2r/d3r | 11 |
8 | jinqi | 10 |
9 | retard-released | 9 |
10 | angong | 8 |
11 | clavulanate-potentiated | 8 |
12 | qili | 8 |
13 | 25-desacetyl | 7 |
14 | liposome-based | 7 |
15 | zhibai | 7 |
16 | n-desalkyl | 6 |
17 | obesity-promoting | 6 |
18 | tianwang | 6 |
19 | 700-mg | 5 |
20 | atd/bal | 5 |
21 | intragastrical | 5 |
22 | nonparenteral | 5 |
23 | whole-tablet | 5 |
24 | xuefu | 5 |
25 | 40-g | 4 |
26 | alcohol-cue | 4 |
27 | isosmolar | 4 |
28 | shaofu | 4 |
29 | 69.4mg | 3 |
30 | budesonide/ | 3 |
31 | corn-oil | 3 |
32 | corticolous | 3 |
33 | de-escalatory | 3 |
34 | electric-powered | 3 |
35 | fugui | 3 |
36 | intratumoural | 3 |
37 | intrawound | 3 |
38 | liangxue | 3 |
39 | nsaid/ppi | 3 |
40 | oestrogen-containing | 3 |
41 | olanzapine/ | 3 |
42 | progestin-based | 3 |
43 | qiju | 3 |
44 | qinghuo | 3 |
45 | shufeng | 3 |
46 | sustained-released | 3 |
47 | tumor-targeted | 3 |
48 | user-controlled | 3 |
49 | 145-mg | 2 |
50 | 1st-time | 2 |
51 | 3-gram | 2 |
52 | alcohol/placebo | 2 |
53 | ampicillin/ | 2 |
54 | anthelminth | 2 |
55 | buccal/sublingual | 2 |
56 | calcigard-10 | 2 |
57 | chlorofluorocarbon-delivered | 2 |
58 | enoxaparin-vka | 2 |
59 | higher-than-recommended | 2 |
60 | intermittent-infusion | 2 |
61 | intra-canal | 2 |
62 | intra-cochlear | 2 |
63 | ketamine-assisted | 2 |
64 | loss-focused | 2 |
65 | nonpowder | 2 |
66 | paraendocervical | 2 |
67 | per-oral | 2 |
68 | pre-extinction | 2 |
69 | progesten-only | 2 |
70 | shenyan | 2 |
71 | shuangshen | 2 |
72 | study-agent | 2 |
73 | sub-antimicrobial-dose | 2 |
74 | unmetabolised | 2 |
75 | 2.5:11.5-mg-base/kg | 1 |
76 | 3-nitrotriazole-based | 1 |
77 | 4-1g | 1 |
78 | 4-mg/day | 1 |
79 | 40-million | 1 |
80 | 400mcg | 1 |
81 | 5-mg/kg/week | 1 |
82 | 553-patient | 1 |
83 | allowance/intake | 1 |
84 | amezinium | 1 |
85 | antibimcrobials | 1 |
86 | antibiotics.the | 1 |
87 | avp-induced | 1 |
88 | bacteriocide | 1 |
89 | ban-xia | 1 |
90 | befre | 1 |
91 | benzodiazepine-derivative | 1 |
92 | bis-coumarin | 1 |
93 | bupivacaine/ | 1 |
94 | cefazolin-cephalothin | 1 |
95 | cimteropium/ | 1 |
96 | coprandial | 1 |
97 | cpfx-cam | 1 |
98 | cyclosporine/ | 1 |
99 | diet/oral | 1 |
100 | diyu | 1 |
101 | easyhalers | 1 |
102 | endectocide | 1 |
103 | esterefied | 1 |
104 | extra-strength | 1 |
105 | fast-disintegrating/rapid-release | 1 |
106 | fpm-1-mediated | 1 |
107 | free-from-failure | 1 |
108 | gabapentoid | 1 |
109 | gastro-gavage | 1 |
110 | gate-first | 1 |
111 | glutenase | 1 |
112 | groups.lai | 1 |
113 | hrt/conjugated | 1 |
114 | huazhuo | 1 |
115 | huchang | 1 |
116 | hydrocortisone/placebo | 1 |
117 | indefinite-duration | 1 |
118 | intra-colonic | 1 |
119 | intra-pvn | 1 |
120 | intra-radial | 1 |
121 | intramuscular/vector | 1 |
122 | intraportal/vector | 1 |
123 | irradiation/shielding | 1 |
124 | kdm+/chd-and | 1 |
125 | laiv-iiv | 1 |
126 | lipase-labile | 1 |
127 | mayoral | 1 |
128 | metafolin | 1 |
129 | nct01341275 | 1 |
130 | nonclient | 1 |
131 | np-ms. | 1 |
132 | nutriceutical/placebo | 1 |
133 | odti | 1 |
134 | outcomes.systemic | 1 |
135 | outpatient-controlled | 1 |
136 | oxprenolol-induced | 1 |
137 | pihui | 1 |
138 | placebo/probiotic | 1 |
139 | placebo/sedative | 1 |
140 | post-amniotomy | 1 |
141 | post-gci | 1 |
142 | practiceprolonged | 1 |
143 | preexam | 1 |
144 | prescrrption | 1 |
145 | provider-dependent | 1 |
146 | rengong | 1 |
147 | roziglitasone | 1 |
148 | shashen | 1 |
149 | shengrue | 1 |
150 | slow-rapid | 1 |
151 | spitted | 1 |
152 | student-to-student | 1 |
153 | sulfa-free | 1 |
154 | sulfamethoxazole/ | 1 |
155 | sulfamethozole | 1 |
156 | transamniotic | 1 |
157 | tricontinental | 1 |
158 | tubefeed | 1 |
159 | usa-canada | 1 |
160 | uv-pes/computational | 1 |
161 | wanshi | 1 |
162 | who¿s | 1 |
163 | yixin | 1 |
164 | zhengqing | 1 |
165 | zylexis | 1 |
1 | 145-mg | 2 |
2 | 1st-time | 2 |
3 | 2.5:11.5-mg-base/kg | 1 |
4 | 25-desacetyl | 7 |
5 | 3-gram | 2 |
6 | 3-nitrotriazole-based | 1 |
7 | 4-1g | 1 |
8 | 4-mg/day | 1 |
9 | 40-g | 4 |
10 | 40-million | 1 |
11 | 400mcg | 1 |
12 | 5-hydroxymethyl | 15 |
13 | 5-mg/kg/week | 1 |
14 | 553-patient | 1 |
15 | 69.4mg | 3 |
16 | 700-mg | 5 |
17 | alcohol-cue | 4 |
18 | alcohol/placebo | 2 |
19 | allowance/intake | 1 |
20 | amezinium | 1 |
21 | ampicillin/ | 2 |
22 | angong | 8 |
23 | anthelminth | 2 |
24 | antibimcrobials | 1 |
25 | antibiotics.the | 1 |
26 | atd/bal | 5 |
27 | avp-induced | 1 |
28 | bacteriocide | 1 |
29 | ban-xia | 1 |
30 | befre | 1 |
31 | benzodiazepine-derivative | 1 |
32 | bis-coumarin | 1 |
33 | buccal/sublingual | 2 |
34 | budesonide/ | 3 |
35 | bupivacaine/ | 1 |
36 | calcigard-10 | 2 |
37 | cefazolin-cephalothin | 1 |
38 | chlorofluorocarbon-delivered | 2 |
39 | cimteropium/ | 1 |
40 | clavulanate-potentiated | 8 |
41 | coprandial | 1 |
42 | corn-oil | 3 |
43 | corticolous | 3 |
44 | cpfx-cam | 1 |
45 | cyclosporine/ | 1 |
46 | d2r/d3r | 11 |
47 | de-escalatory | 3 |
48 | diet/oral | 1 |
49 | diyu | 1 |
50 | easyhalers | 1 |
51 | electric-powered | 3 |
52 | endectocide | 1 |
53 | enoxaparin-vka | 2 |
54 | esterefied | 1 |
55 | extra-strength | 1 |
56 | fast-disintegrating/rapid-release | 1 |
57 | fpm-1-mediated | 1 |
58 | free-from-failure | 1 |
59 | fugui | 3 |
60 | gabapentoid | 1 |
61 | gastro-gavage | 1 |
62 | gate-first | 1 |
63 | glutenase | 1 |
64 | groups.lai | 1 |
65 | higher-than-recommended | 2 |
66 | hrt/conjugated | 1 |
67 | huazhuo | 1 |
68 | huchang | 1 |
69 | hydrocortisone/placebo | 1 |
70 | indefinite-duration | 1 |
71 | intermittent-infusion | 2 |
72 | intra-canal | 2 |
73 | intra-cochlear | 2 |
74 | intra-colonic | 1 |
75 | intra-pvn | 1 |
76 | intra-radial | 1 |
77 | intragastrical | 5 |
78 | intramuscular/vector | 1 |
79 | intraportal/vector | 1 |
80 | intratumoural | 3 |
81 | intravaginal | 485 |
82 | intrawound | 3 |
83 | irradiation/shielding | 1 |
84 | isosmolar | 4 |
85 | jinqi | 10 |
86 | kdm+/chd-and | 1 |
87 | ketamine-assisted | 2 |
88 | laiv-iiv | 1 |
89 | liangxue | 3 |
90 | lipase-labile | 1 |
91 | liposome-based | 7 |
92 | liuwei | 30 |
93 | loss-focused | 2 |
94 | macrocrystalline | 18 |
95 | mayoral | 1 |
96 | metafolin | 1 |
97 | n-desalkyl | 6 |
98 | nct01341275 | 1 |
99 | nonclient | 1 |
100 | nonoral | 15 |
101 | nonparenteral | 5 |
102 | nonpowder | 2 |
103 | np-ms. | 1 |
104 | nsaid/ppi | 3 |
105 | nutriceutical/placebo | 1 |
106 | obesity-promoting | 6 |
107 | odti | 1 |
108 | oestrogen-containing | 3 |
109 | olanzapine/ | 3 |
110 | oral | 36,448 |
111 | outcomes.systemic | 1 |
112 | outpatient-controlled | 1 |
113 | oxprenolol-induced | 1 |
114 | paraendocervical | 2 |
115 | per-oral | 2 |
116 | pihui | 1 |
117 | placebo/probiotic | 1 |
118 | placebo/sedative | 1 |
119 | post-amniotomy | 1 |
120 | post-gci | 1 |
121 | practiceprolonged | 1 |
122 | pre-extinction | 2 |
123 | preexam | 1 |
124 | prescrrption | 1 |
125 | progesten-only | 2 |
126 | progestin-based | 3 |
127 | provider-dependent | 1 |
128 | qiju | 3 |
129 | qili | 8 |
130 | qinghuo | 3 |
131 | rengong | 1 |
132 | retard-released | 9 |
133 | roziglitasone | 1 |
134 | shaofu | 4 |
135 | shashen | 1 |
136 | shengrue | 1 |
137 | shenyan | 2 |
138 | shuangshen | 2 |
139 | shufeng | 3 |
140 | slow-rapid | 1 |
141 | spitted | 1 |
142 | student-to-student | 1 |
143 | study-agent | 2 |
144 | sub-antimicrobial-dose | 2 |
145 | sulfa-free | 1 |
146 | sulfamethoxazole/ | 1 |
147 | sulfamethozole | 1 |
148 | sustained-released | 3 |
149 | tianwang | 6 |
150 | transamniotic | 1 |
151 | tricontinental | 1 |
152 | tubefeed | 1 |
153 | tumor-targeted | 3 |
154 | unmetabolised | 2 |
155 | usa-canada | 1 |
156 | user-controlled | 3 |
157 | uv-pes/computational | 1 |
158 | wanshi | 1 |
159 | whole-tablet | 5 |
160 | who¿s | 1 |
161 | xuefu | 5 |
162 | yixin | 1 |
163 | zhengqing | 1 |
164 | zhibai | 7 |
165 | zylexis | 1 |
1 | np-ms. | 1 |
2 | budesonide/ | 3 |
3 | sulfamethoxazole/ | 1 |
4 | bupivacaine/ | 1 |
5 | olanzapine/ | 3 |
6 | cyclosporine/ | 1 |
7 | cimteropium/ | 1 |
8 | ampicillin/ | 2 |
9 | calcigard-10 | 2 |
10 | nct01341275 | 1 |
11 | usa-canada | 1 |
12 | ban-xia | 1 |
13 | enoxaparin-vka | 2 |
14 | outcomes.systemic | 1 |
15 | intra-colonic | 1 |
16 | placebo/probiotic | 1 |
17 | transamniotic | 1 |
18 | oxprenolol-induced | 1 |
19 | avp-induced | 1 |
20 | higher-than-recommended | 2 |
21 | tubefeed | 1 |
22 | practiceprolonged | 1 |
23 | esterefied | 1 |
24 | user-controlled | 3 |
25 | outpatient-controlled | 1 |
26 | chlorofluorocarbon-delivered | 2 |
27 | electric-powered | 3 |
28 | 3-nitrotriazole-based | 1 |
29 | liposome-based | 7 |
30 | progestin-based | 3 |
31 | sustained-released | 3 |
32 | retard-released | 9 |
33 | unmetabolised | 2 |
34 | loss-focused | 2 |
35 | hrt/conjugated | 1 |
36 | fpm-1-mediated | 1 |
37 | clavulanate-potentiated | 8 |
38 | tumor-targeted | 3 |
39 | ketamine-assisted | 2 |
40 | spitted | 1 |
41 | gabapentoid | 1 |
42 | slow-rapid | 1 |
43 | kdm+/chd-and | 1 |
44 | intrawound | 3 |
45 | bacteriocide | 1 |
46 | endectocide | 1 |
47 | sulfa-free | 1 |
48 | gastro-gavage | 1 |
49 | antibiotics.the | 1 |
50 | allowance/intake | 1 |
51 | lipase-labile | 1 |
52 | sulfamethozole | 1 |
53 | 1st-time | 2 |
54 | macrocrystalline | 18 |
55 | roziglitasone | 1 |
56 | befre | 1 |
57 | free-from-failure | 1 |
58 | fast-disintegrating/rapid-release | 1 |
59 | glutenase | 1 |
60 | sub-antimicrobial-dose | 2 |
61 | alcohol-cue | 4 |
62 | shengrue | 1 |
63 | liangxue | 3 |
64 | placebo/sedative | 1 |
65 | benzodiazepine-derivative | 1 |
66 | 40-g | 4 |
67 | 4-1g | 1 |
68 | 400mcg | 1 |
69 | 2.5:11.5-mg-base/kg | 1 |
70 | 700-mg | 5 |
71 | 145-mg | 2 |
72 | 69.4mg | 3 |
73 | huchang | 1 |
74 | tianwang | 6 |
75 | shufeng | 3 |
76 | irradiation/shielding | 1 |
77 | oestrogen-containing | 3 |
78 | zhengqing | 1 |
79 | obesity-promoting | 6 |
80 | angong | 8 |
81 | rengong | 1 |
82 | extra-strength | 1 |
83 | anthelminth | 2 |
84 | zhibai | 7 |
85 | groups.lai | 1 |
86 | post-gci | 1 |
87 | liuwei | 30 |
88 | wanshi | 1 |
89 | qili | 8 |
90 | nsaid/ppi | 3 |
91 | jinqi | 10 |
92 | odti | 1 |
93 | fugui | 3 |
94 | pihui | 1 |
95 | 5-mg/kg/week | 1 |
96 | atd/bal | 5 |
97 | intragastrical | 5 |
98 | paraendocervical | 2 |
99 | intra-radial | 1 |
100 | coprandial | 1 |
101 | intra-canal | 2 |
102 | intravaginal | 485 |
103 | uv-pes/computational | 1 |
104 | nonparenteral | 5 |
105 | oral | 36,448 |
106 | per-oral | 2 |
107 | diet/oral | 1 |
108 | nonoral | 15 |
109 | mayoral | 1 |
110 | intratumoural | 3 |
111 | tricontinental | 1 |
112 | buccal/sublingual | 2 |
113 | corn-oil | 3 |
114 | 5-hydroxymethyl | 15 |
115 | n-desalkyl | 6 |
116 | 25-desacetyl | 7 |
117 | cpfx-cam | 1 |
118 | 3-gram | 2 |
119 | preexam | 1 |
120 | amezinium | 1 |
121 | shenyan | 2 |
122 | shashen | 1 |
123 | shuangshen | 2 |
124 | cefazolin-cephalothin | 1 |
125 | metafolin | 1 |
126 | bis-coumarin | 1 |
127 | yixin | 1 |
128 | 40-million | 1 |
129 | intermittent-infusion | 2 |
130 | indefinite-duration | 1 |
131 | pre-extinction | 2 |
132 | prescrrption | 1 |
133 | intra-pvn | 1 |
134 | hydrocortisone/placebo | 1 |
135 | nutriceutical/placebo | 1 |
136 | alcohol/placebo | 2 |
137 | qinghuo | 3 |
138 | huazhuo | 1 |
139 | d2r/d3r | 11 |
140 | intra-cochlear | 2 |
141 | isosmolar | 4 |
142 | nonpowder | 2 |
143 | intraportal/vector | 1 |
144 | intramuscular/vector | 1 |
145 | zylexis | 1 |
146 | antibimcrobials | 1 |
147 | easyhalers | 1 |
148 | corticolous | 3 |
149 | who¿s | 1 |
150 | whole-tablet | 5 |
151 | provider-dependent | 1 |
152 | student-to-student | 1 |
153 | study-agent | 2 |
154 | nonclient | 1 |
155 | 553-patient | 1 |
156 | gate-first | 1 |
157 | xuefu | 5 |
158 | shaofu | 4 |
159 | qiju | 3 |
160 | diyu | 1 |
161 | laiv-iiv | 1 |
162 | 4-mg/day | 1 |
163 | progesten-only | 2 |
164 | post-amniotomy | 1 |
165 | de-escalatory | 3 |